- ASSISTANT PROFESSOR Neurology
Neurology, American Board of Psychiatry and Neurology
MD, Mount Sinai School of Medicine
Internship, Internal Medicine
Jacobi Hospital Center
Columbia University Medical Center
Fellowship, Stroke & Neuro-Intensive Care
Columbia University Medical Center
Mandip S. Dhamoon, MD, MPH is an Assistant Professor of Neurology at the Mount Sinai Medical Center. He received a B.A. from Williams College and an M.D. from Mount Sinai School of Medicine. He completed an internship at Jacobi Medical Center, and a neurology residency and fellowship in cerebrovascular disease and neuroepidemiology at Columbia University. He received an MPH from the Mailman School of Public Health and is currently in the dissertation phase of a DrPH degree in epidemiology.
Dr. Dhamoon’s research interests include modeling outcomes related to stroke, estimation of risk of vascular disease, and the impact of stroke on functional status and quality of life. Under the mentorship of Dr. Mitchell Elkind, he has published data from the Northern Manhattan Study about the risk of cardiac events and recurrent stroke after first ischemic stroke. He has examined the natural history and predictors of post-stroke disability and found that there was a decline in the proportion of patients overall who had good functional outcome over time after stroke, especially those who were uninsured or insured with Medicaid. Another analysis showed similar results for the outcome of quality of life. With Dr. Elkind, he has published a review as a “Special Report” in Circulation on the inclusion of stroke in risk estimation and primary and secondary prevention, and he was a writing member on an American Heart Association statement on this topic. More recent papers have modeled the impact of including stroke in risk estimation of vascular disease and the course of functional decline before and after stroke. He also has begun collaborations on analyses with the Secondary Prevention of Small Subcortical Strokes study and the Cardiovascular Health Study, examining the functional status and quality of life before and after stroke.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Dhamoon did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 2nd Room 230
1468 Madison Avenue
New York, NY 10029
5 East 98th Street 7th floor
NYC, NY 10029